Education
About Us
Working with TipRanks
Follow Us
Mangalam Drugs & Organics Ltd. (IN:MANGALAM)
:MANGALAM
Total Valuation
Mangalam Drugs & Organics Ltd. has a market cap or net worth of ₹1.29B. The enterprise value is ―.
Market Cap₹1.29B
Enterprise Value―
Share Statistics
Mangalam Drugs & Organics Ltd. has 15,828,248 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,828,248
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mangalam Drugs & Organics Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Mangalam Drugs & Organics Ltd. is ―. Mangalam Drugs & Organics Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Mangalam Drugs & Organics Ltd. had revenue of 3.67B and earned -90.72M in profits. Earnings per share was -5.73.
Revenue3.67B
Gross Profit188.12M
Operating Income27.46M
Pretax Income-110.73M
Net Income-90.72M
EBITDA139.86M
Earnings Per Share (EPS)-5.73
Cash Flow
In the last 12 months, operating cash flow was 147.36M and capital expenditures 0.00, giving a free cash flow of 147.36M billion.
Operating Cash Flow147.36M
Free Cash Flow147.36M
Free Cash Flow per Share9.31
Dividends & Yields
Mangalam Drugs & Organics Ltd. pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.13
52-Week Price Change-16.93%
50-Day Moving Average78.84
200-Day Moving Average104.58
Relative Strength Index (RSI)57.80
Average Volume (3m)4.83K
Important Dates
Mangalam Drugs & Organics Ltd. upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 17, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateDec 21, 2017
Financial Position
Mangalam Drugs & Organics Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Mangalam Drugs & Organics Ltd. has paid -20.02M in taxes.
Income Tax-20.02M
Effective Tax Rate―
Enterprise Valuation
Mangalam Drugs & Organics Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Mangalam Drugs & Organics Ltd. has ₹9.11M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹9.11M billion.
Cash & Marketable Securities₹9.11M
Total Debt₹0.00
Net Cash-₹9.11M
Net Cash Per Share-₹0.58
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Mangalam Drugs & Organics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―